Brett Icahn
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
IFF to Report Q3 2026 Results on November 3. International Flavors & Fragrances is scheduled to release its third-quarter 2026 earnings on November 3, 2026. This upcoming report is the primary driver of recent attention for the stock. The company's shares have been trading near the upper end of their 52-week range, with an RSI of 75.3 suggesting strong recent momentum ahead of the announcement.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
BHC appoints interim CEO and looks to raise FY26 EBITDA guidance. Bausch Health announced that its chairman, Thomas J. Appio, will serve as interim chief executive effective immediately. The company and its parent also said they expect to raise the adjusted EBITDA guidance for fiscal year 2026, not including the recently acquired IPR&D business. A separate notice confirms that the firm will release its third‑quarter 2026 results on October 28. Analysts at Zacks included Bausch Health in a recent coverage roundup, highlighting the stock among other health‑care names.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
BLCO Advances Oral Dry AMD Treatment After FDA Meeting. Bausch + Lomb reported progress on a new oral drug for dry age‑related macular degeneration after a constructive meeting with the FDA. The company said the discussion helped clarify the regulatory pathway and the drug’s development plan. It also announced that its third‑quarter 2026 earnings will be released on Oct. 28, giving investors a future update on performance.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
IEP Featured in Whale Alerts and Dividend Risk Lists. Icahn Enterprises L.P. appeared in recent market reports highlighting unusual trading volume and potential risks associated with its high dividend yield. These mentions draw attention to the stock's current valuation and payout structure. The news serves as a reminder for investors to review the underlying financial health behind the reported yield.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Newell Brands (NWL) Faces Valuation Questions Amid Sector Slowdown. Recent coverage highlights whether Newell Brands is undervalued while its peer Kimberly-Clark navigates slower growth in consumer categories. The stock is currently trading near a key support level, with analysts maintaining a wide range of price targets. This context suggests investors are weighing fundamental value against broader sector headwinds.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Dana Gets EU Approval For Eaton Mobility Deal. Dana Incorporated has received European Commission approval to acquire Eaton's mobility operations. This regulatory green light is a key step in finalizing the transaction, which aims to expand Dana's presence in the European market. The approval removes a major uncertainty that had been weighing on the deal's timeline.
Transaction History
| SD | ▲ Buy | Grant | 9,804 | $150K | 6/10/2026 | View on chart |
| IFF | ▲ Buy | Option Exercise | 1,712 | $0 | 5/1/2026 | View on chart |
| IFF | ▲ Buy | Grant | 13,000 | $838K | 11/11/2025 | View on chart |
| IFF | ▲ Buy | Grant | 20,000 | $1.3M | 11/10/2025 | View on chart |
| SD | ▲ Buy | Grant | 12,905 | $129K | 8/1/2025 | View on chart |
| BHC | ▲ Buy | Grant | 4,034 | $0 | 6/30/2025 | View on chart |
| BLCO | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 | View on chart |
| BHC | ▲ Buy | Grant | 54,347 | $0 | 5/16/2025 | View on chart |
| BHC | ▲ Buy | Grant | 5,119 | $33K | 3/31/2025 | View on chart |
| BHC | ▲ Buy | Grant | 4,109 | $33K | 12/31/2024 | View on chart |
| IEP | ▼ Sell | Tax Withholding | 34,179 | $457K | 9/30/2024 | View on chart |
| BHC | ▲ Buy | Grant | 4,059 | $33K | 9/30/2024 | View on chart |
| BLCO | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 | View on chart |
| BHC | ▲ Buy | Grant | 4,752 | $33K | 6/28/2024 | View on chart |
| BHC | ▲ Buy | Grant | 35,360 | $0 | 5/17/2024 | View on chart |
| BHC | ▲ Buy | Grant | 3,122 | $33K | 3/29/2024 | View on chart |
| BHC | ▲ Buy | Grant | 4,130 | $33K | 12/29/2023 | View on chart |
| IEP | ▼ Sell | Tax Withholding | 29,206 | $588K | 9/30/2023 | View on chart |
| BHC | ▲ Buy | Grant | 4,029 | $33K | 9/29/2023 | View on chart |
| BHC | ▲ Buy | Grant | 4,140 | $33K | 6/30/2023 | View on chart |
| BHC | ▲ Buy | Grant | 29,205 | $0 | 5/19/2023 | View on chart |
| BLCO | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 | View on chart |
| BHC | ▲ Buy | Grant | 3,684 | $30K | 3/31/2023 | View on chart |
| NWL | ▼ Sell | Open Market | 374,628 | $5.6M | 2/17/2023 | View on chart |
| NWL | ▼ Sell | Open Market | 91,714 | $1.4M | 2/17/2023 | View on chart |
| DAN | ▲ Buy | Option Exercise | 6,578 | $0 | 2/16/2023 | View on chart |
| DAN | ▲ Buy | Option Exercise | 159 | $0 | 2/16/2023 | View on chart |
| NWL | ▼ Sell | Open Market | 107,372 | $1.7M | 2/16/2023 | View on chart |
| NWL | ▼ Sell | Open Market | 26,286 | $404K | 2/16/2023 | View on chart |
| BHC | ▲ Buy | Grant | 4,589 | $29K | 12/30/2022 | View on chart |
| IEP | ▼ Sell | Tax Withholding | 17,920 | $892K | 9/30/2022 | View on chart |
| BHC | ▲ Buy | Grant | 4,444 | $31K | 9/30/2022 | View on chart |
| NWL | ▼ Sell | Open Market | 71,304 | $1.2M | 9/14/2022 | View on chart |
| NWL | ▼ Sell | Open Market | 10,000 | $171K | 9/14/2022 | View on chart |
| NWL | ▼ Sell | Open Market | 150,000 | $2.6M | 9/13/2022 | View on chart |
| NWL | ▼ Sell | Open Market | 150,000 | $2.6M | 9/13/2022 | View on chart |
| BHC | ▲ Buy | Grant | 3,663 | $31K | 6/30/2022 | View on chart |
| BLCO | ▲ Buy | Grant | 13,256 | $0 | 6/28/2022 | View on chart |
| BHC | ▲ Buy | Grant | 34,387 | $0 | 6/24/2022 | View on chart |
| NWL | ▲ Buy | Option Exercise | 5,167 | $0 | 5/4/2022 | View on chart |
| BHC | ▲ Buy | Grant | 1,340 | $31K | 3/31/2022 | View on chart |
| BHC | ▲ Buy | Grant | 1,109 | $31K | 12/31/2021 | View on chart |
| IEP | ▼ Sell | Tax Withholding | 15,688 | $785K | 9/30/2021 | View on chart |
| BHC | ▲ Buy | Grant | 1,099 | $31K | 9/30/2021 | View on chart |
| IEP | ▲ Buy | Grant | 239,254 | $0 | 10/1/2020 | View on chart |
| IEP | ▲ Buy | Open Market | 202,758 | $10.0M | 10/1/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
SandRidge Energy Reviewed in Yahoo Energy Stock Comparison
The Yahoo article compares SandRidge Energy to PrimeEnergy, examining factors like valuation and dividend yield. SandRidge trades with a trailing P/E of 6.1 and a 2.76% dividend, and analysts set a target of $14.00. The piece highlights how SandRidge’s metrics stack against its peer, providing context for investors.
SandRidge Energy Reviewed in Yahoo Energy Stock Comparison. The Yahoo article compares SandRidge Energy to PrimeEnergy, examining factors like valuation and dividend yield. SandRidge trades with a trailing P/E of 6.1 and a 2.76% dividend, and analysts set a target of $14.00. The piece highlights how SandRidge’s metrics stack against its peer, providing context for investors.